SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
This additional acquisition in Spain market increases DESMA Spain’s footprint and business.
SIT Group is pleased to announce the acquisition of established product SULMETIN from Sanofi, as a result of the agreement signed on November 8, 2022.
This additional acquisition in Spain market increases DESMA Spain’s footprint and business.
